Prenetics Global Limited Class A Ordinary Share (PRE)

$15.72 +0.85 (5.68%)
Market Cap 264.54M
Revenue (ttm) 30.62M
Net Income (ttm) -46.30M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 10.41
Profit Margin -151.21%
Debt to Equity Ratio 0.00
Volume 216,600
Avg Vol 152,304
Day's Range N/A - N/A
Shares Out 16.83M
Stochastic %K 26%
Beta 0.34
Analysts Sell
Price Target $31.00

Company Profile

Prenetics Global Limited, a health sciences company, focuses on advancing consumer health in Hong Kong, the United States, and internationally. It sells health and wellness products under the IM8 brand name; and provides fulfillment and distribution services for sports nutrition products under the Europa brand. The company is also involved in the operation of CircleDNA, a consumer genetic testing brand that uses next-generation sequencing (NGS) technology to provide comprehensive insights into h...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 852 2210 9588
Address:
Unit 703-706, K11 Atelier King’s Road, 728 King’s Road, Quarry Bay, Hong Kong
JohnTrack
JohnTrack Jan. 6 at 1:16 PM
$PRE fresh mention!! https://www.rapidticker.com/news/pre-sec-filing-bcfe23
0 · Reply
JohnTrack
JohnTrack Jan. 5 at 5:46 PM
$PRE waiting on clean signal...
0 · Reply
JohnTrack
JohnTrack Jan. 5 at 1:47 PM
$PRE new drop for the ticker!! https://www.rapidticker.com/news/pre-sec-filing-54fdcf
0 · Reply
topstockalerts
topstockalerts Jan. 2 at 9:40 PM
After Hours Top Gainers $GHRS $CUE $PRE $PASW $CAMP
0 · Reply
JohnTrack
JohnTrack Dec. 30 at 1:16 PM
$PRE wire mention on the company https://www.rapidticker.com/news/pre-prenetics-announces-update-to-capital-53ba91
0 · Reply
BioTechHealthX
BioTechHealthX Dec. 27 at 11:45 PM
$PRE Prenetics Global Limited (NASDAQ: PRE) is increasingly associated with consumer wellness acceleration and longevity brand demand. Discover how PRE’s health and wellness products, sports nutrition products, and global footprint are fueling a finance narrative investors are chasing for the next breakout. https://biotechhealthx.com/biotech-news/is-prenetics-global-limited-pre-the-fastest-growing-supplement-brand-story-wall-street-cant-ignore/
0 · Reply
GranularGlow
GranularGlow Dec. 27 at 5:55 PM
$PRE Short‑term swings mask the deeper question: can discipline hold; pipeline visibility needs clearer corroboration — a credible cadence of milestones would shift sentiment. Only demonstrated reliability will sustain upside potential.
0 · Reply
CartographerC
CartographerC Dec. 25 at 11:23 AM
$PRE Market behavior suggests investors are rewarding credible delivery more than theoretical upside. Progress needs to be observable in both leading indicators and reported metrics. Sharper prioritization may be required to avoid execution dilution. Future re‑rating depends on tightening the gap between narrative and reality.
0 · Reply
DARKP00L
DARKP00L Dec. 23 at 2:34 PM
$PRE 09:11 on Dec. 23 2025 Prenetics Launches Voluntary Warrant Exchange Program, Representing ~83.4% Of Outstanding Class A and B Warrants; Aims To Simplify Capital Structure, Reduce Potential Dilution By Up To 50%, Consolidate Legacy Warrants Into Single Class C Warrants #tradeideas
0 · Reply
DARKP00L
DARKP00L Dec. 23 at 2:25 PM
$PRE 09:11 on Dec. 23 2025 Prenetics Launches Voluntary Warrant Exchange Program, Representing ~83.4% Of Outstanding Class A and B Warrants; Aims To Simplify Capital Structure, Reduce Potential Dilution By Up To 50%, Consolidate Legacy Warrants Into Single Class C Warrants #tradeideas
0 · Reply
Latest News on PRE
Buying bitcoin is no longer a thing for this David Beckham-backed health company

Dec 30, 2025, 3:06 PM EST - 17 days ago

Buying bitcoin is no longer a thing for this David Beckham-backed health company

MSTR

Prenetics Enters Into Warrant Exchange Agreements With Warrant Holders, Strengthening Capital Structure

Dec 23, 2025, 9:08 AM EST - 24 days ago

Prenetics Enters Into Warrant Exchange Agreements With Warrant Holders, Strengthening Capital Structure

Prenetics Announces Upcoming Conference Participation

Nov 25, 2025, 8:49 AM EST - 7 weeks ago

Prenetics Announces Upcoming Conference Participation

Prenetics Executives Announce Open Market Share Purchases Totaling Approx. $1.45 Million

Nov 24, 2025, 7:30 AM EST - 7 weeks ago

Prenetics Executives Announce Open Market Share Purchases Totaling Approx. $1.45 Million

Cantor Fitzgerald Reiterates Overweight Rating on Prenetics with Price Target of $31 Following Strong IM8 Growth

Nov 14, 2025, 8:35 AM EST - 2 months ago

Cantor Fitzgerald Reiterates Overweight Rating on Prenetics with Price Target of $31 Following Strong IM8 Growth

Prenetics Reports Record Third Quarter 2025 Results; IM8 on Track for $120M ARR¹ by December 2025, Fastest Supplement Brand Growth in Industry History

Nov 10, 2025, 7:24 AM EST - 2 months ago

Prenetics Reports Record Third Quarter 2025 Results; IM8 on Track for $120M ARR¹ by December 2025, Fastest Supplement Brand Growth in Industry History

EXOD

Prenetics' IM8 Achieves Record $9 Million in Revenue for October, Surpasses $108 Million in Annualized Recurring Revenue 11 Months After Launch

Nov 4, 2025, 8:00 AM EST - 2 months ago

Prenetics' IM8 Achieves Record $9 Million in Revenue for October, Surpasses $108 Million in Annualized Recurring Revenue 11 Months After Launch

Prenetics Bolsters Bitcoin Treasury with Strategic Acquisition of 100 Bitcoin, IM8 Reaches $100M ARR

Oct 31, 2025, 8:31 AM EDT - 2 months ago

Prenetics Bolsters Bitcoin Treasury with Strategic Acquisition of 100 Bitcoin, IM8 Reaches $100M ARR

Prenetics CEO Danny Yeung Publishes "The Dual-Engine Revolution" Manifesto: A Blueprint for the Future of Health + Wealth

Oct 29, 2025, 4:05 PM EDT - 2 months ago

Prenetics CEO Danny Yeung Publishes "The Dual-Engine Revolution" Manifesto: A Blueprint for the Future of Health + Wealth

Prenetics Announces Closing of Approx. $44.0 Million Equity Offering to Fuel IM8's Global Expansion and Bitcoin Treasury Strategy

Oct 28, 2025, 2:20 PM EDT - 2 months ago

Prenetics Announces Closing of Approx. $44.0 Million Equity Offering to Fuel IM8's Global Expansion and Bitcoin Treasury Strategy

Prenetics Announces Oversubscribed Approximately $48 Million Equity Offering with Potential for $216 Million in Total Proceeds to Fuel IM8's Global Expansion and Bitcoin Treasury Strategy

Oct 27, 2025, 10:12 AM EDT - 2 months ago

Prenetics Announces Oversubscribed Approximately $48 Million Equity Offering with Potential for $216 Million in Total Proceeds to Fuel IM8's Global Expansion and Bitcoin Treasury Strategy

Prenetics: A Cautious Buy Based On Strong Sales Growth

Oct 9, 2025, 12:58 AM EDT - 3 months ago

Prenetics: A Cautious Buy Based On Strong Sales Growth

Prenetics' IM8 Launches Daily Ultimate Longevity, First Supplement to Target All 12 Hallmarks of Aging

Oct 8, 2025, 8:04 AM EDT - 3 months ago

Prenetics' IM8 Launches Daily Ultimate Longevity, First Supplement to Target All 12 Hallmarks of Aging

Prenetics Announces CEO Danny Yeung Keynote at Token 2049 Singapore

Sep 30, 2025, 8:00 AM EDT - 3 months ago

Prenetics Announces CEO Danny Yeung Keynote at Token 2049 Singapore

Prenetics Announces Second Quarter 2025 Financial Results with IM8 on Track to Achieve $100M Annual Recurring Revenue by Year's End

Sep 12, 2025, 8:30 AM EDT - 4 months ago

Prenetics Announces Second Quarter 2025 Financial Results with IM8 on Track to Achieve $100M Annual Recurring Revenue by Year's End

World No. 1 Tennis Star Aryna Sabalenka Joins Prenetics' IM8 Health as Global Ambassador and Shareholder

Jun 26, 2025, 4:30 AM EDT - 7 months ago

World No. 1 Tennis Star Aryna Sabalenka Joins Prenetics' IM8 Health as Global Ambassador and Shareholder

Prenetics Becomes First Healthcare Company to Execute Aggressive Bitcoin Treasury Strategy, Secures $20M in BTC, Appoints Former OKEx COO to Board

Jun 18, 2025, 8:45 AM EDT - 7 months ago

Prenetics Becomes First Healthcare Company to Execute Aggressive Bitcoin Treasury Strategy, Secures $20M in BTC, Appoints Former OKEx COO to Board

Prenetics Divests ACT Genomics to Delta Electronics as Part of up to US$71.78 Million Transaction

Jun 18, 2025, 7:50 AM EDT - 7 months ago

Prenetics Divests ACT Genomics to Delta Electronics as Part of up to US$71.78 Million Transaction

Prenetics' IM8 Health Expands Scientific Advisory Board, Reinforcing Commitment to Set New Standards in Supplements Market

Mar 18, 2025, 8:30 AM EDT - 10 months ago

Prenetics' IM8 Health Expands Scientific Advisory Board, Reinforcing Commitment to Set New Standards in Supplements Market

Prenetics Announces Fourth Quarter and Full Year 2024 Financial Results, Provides 2025 Guidance

Mar 5, 2025, 8:30 AM EST - 11 months ago

Prenetics Announces Fourth Quarter and Full Year 2024 Financial Results, Provides 2025 Guidance

Nasdaq-Listed Prenetics Announces Genomics-Based Partnership with Humanity Protocol and Launches Crypto Strategic Reserve

Feb 11, 2025, 8:30 AM EST - 1 year ago

Nasdaq-Listed Prenetics Announces Genomics-Based Partnership with Humanity Protocol and Launches Crypto Strategic Reserve

Prenetics' IM8 Achieves Prestigious NSF Certified for Sport® for Daily Ultimate Essentials

Jan 15, 2025, 8:30 AM EST - 1 year ago

Prenetics' IM8 Achieves Prestigious NSF Certified for Sport® for Daily Ultimate Essentials

Prenetics' IM8 and University of Oxford Begin Groundbreaking Space Experiment to Study Accelerated Aging and Longevity on the ISS with SpaceX, Supported by Space Applications Services

Dec 5, 2024, 8:30 AM EST - 1 year ago

Prenetics' IM8 and University of Oxford Begin Groundbreaking Space Experiment to Study Accelerated Aging and Longevity on the ISS with SpaceX, Supported by Space Applications Services

Prenetics Announces Participation in December Investor Conferences

Dec 4, 2024, 4:05 PM EST - 1 year ago

Prenetics Announces Participation in December Investor Conferences

Prenetics Announces Third Quarter 2024 Financial Results

Nov 27, 2024, 8:30 AM EST - 1 year ago

Prenetics Announces Third Quarter 2024 Financial Results

MULTIMEDIA UPDATE -- Nasdaq-Listed Prenetics and David Beckham Officially Launch IM8 Health

Nov 18, 2024, 6:57 AM EST - 1 year ago

MULTIMEDIA UPDATE -- Nasdaq-Listed Prenetics and David Beckham Officially Launch IM8 Health

Nasdaq-Listed Prenetics and David Beckham Officially Launch IM8 Health

Nov 18, 2024, 6:00 AM EST - 1 year ago

Nasdaq-Listed Prenetics and David Beckham Officially Launch IM8 Health

Prenetics Announces Participation in the Sidoti Virtual Micro Cap Investor Conference

Oct 30, 2024, 4:15 PM EDT - 1 year ago

Prenetics Announces Participation in the Sidoti Virtual Micro Cap Investor Conference

Prenetics Announces Acquisition of Europa Sports Partners in Strategic Expansion to Consumer Health and Wellness Industry

Aug 19, 2024, 8:30 AM EDT - 1 year ago

Prenetics Announces Acquisition of Europa Sports Partners in Strategic Expansion to Consumer Health and Wellness Industry

Prenetics, NASDAQ Health Sciences Company, Partners with David Beckham

Jul 11, 2024, 8:30 AM EDT - 1 year ago

Prenetics, NASDAQ Health Sciences Company, Partners with David Beckham

Prenetics Welcomes Kathyrn M. Henry and David Vanderveen to Board of Directors

Jul 1, 2024, 8:30 AM EDT - 1 year ago

Prenetics Welcomes Kathyrn M. Henry and David Vanderveen to Board of Directors

Prenetics Announces First Quarter 2024 Financial Results

Jun 18, 2024, 8:30 AM EDT - 1 year ago

Prenetics Announces First Quarter 2024 Financial Results

Prenetics Announces Fourth Quarter and Full Year 2023 Financial Results

Apr 1, 2024, 7:30 AM EDT - 1 year ago

Prenetics Announces Fourth Quarter and Full Year 2023 Financial Results

Prenetics Announces MOU for a Strategic Investment and 5-Year Research Collaboration with Metavisionaries to Pioneer R&D on the International Space Station

Feb 9, 2024, 9:25 AM EST - 2 years ago

Prenetics Announces MOU for a Strategic Investment and 5-Year Research Collaboration with Metavisionaries to Pioneer R&D on the International Space Station

Prenetics Announces Third Quarter 2023 Financial Results

Nov 20, 2023, 6:00 AM EST - 2 years ago

Prenetics Announces Third Quarter 2023 Financial Results

Prenetics Global Limited Announces Reverse Stock Split

Nov 1, 2023, 6:00 AM EDT - 2 years ago

Prenetics Global Limited Announces Reverse Stock Split

Prenetics Announces Second Quarter 2023 Financial Results

Sep 15, 2023, 6:58 AM EDT - 2 years ago

Prenetics Announces Second Quarter 2023 Financial Results

Prenetics CEO discusses $200 million JV for early cancer detection breakthrough

Jun 26, 2023, 2:18 AM EDT - 2 years ago

Prenetics CEO discusses $200 million JV for early cancer detection breakthrough

Prenetics and Globally Renowned Scientist Prof. Dennis Lo Establish US$200m Joint Venture “Insighta” for Breakthrough Multi-Cancer Early Detection Screening

Jun 25, 2023, 8:45 PM EDT - 2 years ago

Prenetics and Globally Renowned Scientist Prof. Dennis Lo Establish US$200m Joint Venture “Insighta” for Breakthrough Multi-Cancer Early Detection Screening

Prenetics Announces First Quarter 2023 Financial Results

Jun 5, 2023, 7:00 AM EDT - 2 years ago

Prenetics Announces First Quarter 2023 Financial Results

Prenetics Announces Fourth Quarter and Full Year 2022 Financial Results

Mar 14, 2023, 8:49 AM EDT - 3 years ago

Prenetics Announces Fourth Quarter and Full Year 2022 Financial Results

Prenetics Announces Formation of Scientific Advisory Board to Support New Business Strategy in Precision Oncology

Mar 2, 2023, 7:00 AM EST - 3 years ago

Prenetics Announces Formation of Scientific Advisory Board to Support New Business Strategy in Precision Oncology

Prenetics to Participate Virtually at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Feb 2, 2023, 4:01 PM EST - 3 years ago

Prenetics to Participate Virtually at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Prenetics Announces Dr. Bayju Thakar as Chief Executive Officer of Prenetics EMEA

Jan 19, 2023, 5:00 AM EST - 3 years ago

Prenetics Announces Dr. Bayju Thakar as Chief Executive Officer of Prenetics EMEA

Prenetics Global's stock rallies 82%

Jan 10, 2023, 8:30 AM EST - 3 years ago

Prenetics Global's stock rallies 82%

Prenetics Owned ACT Genomics Receives FDA Clearance for ACTOnco, the First Asia-Based Company to Receive Clearance for a Comprehensive Genomic Profiling Test for All Solid Tumors

Jan 10, 2023, 6:00 AM EST - 3 years ago

Prenetics Owned ACT Genomics Receives FDA Clearance for ACTOnco, the First Asia-Based Company to Receive Clearance for a Comprehensive Genomic Profiling Test for All Solid Tumors

Prenetics Acquires ACT Genomics, Creating a Leader in Comprehensive Cancer Genetics and Precision Oncology

Dec 16, 2022, 6:27 AM EST - 3 years ago

Prenetics Acquires ACT Genomics, Creating a Leader in Comprehensive Cancer Genetics and Precision Oncology

Prenetics Announces US$20 Million Stock Repurchase Program and Inclusion into the MSCI Global Micro Cap Index

Nov 30, 2022, 9:15 AM EST - 3 years ago

Prenetics Announces US$20 Million Stock Repurchase Program and Inclusion into the MSCI Global Micro Cap Index

Prenetics Announces Record Third Quarter 2022 Financial Results and Raises Full Year 2022 Revenue and EBITDA Guidance

Nov 10, 2022, 8:00 AM EST - 3 years ago

Prenetics Announces Record Third Quarter 2022 Financial Results and Raises Full Year 2022 Revenue and EBITDA Guidance

Prenetics Announces Second Quarter 2022 Financial Results and Raises Full Year Adjusted EBITDA Outlook

Sep 9, 2022, 9:02 AM EDT - 3 years ago

Prenetics Announces Second Quarter 2022 Financial Results and Raises Full Year Adjusted EBITDA Outlook

JohnTrack
JohnTrack Jan. 6 at 1:16 PM
$PRE fresh mention!! https://www.rapidticker.com/news/pre-sec-filing-bcfe23
0 · Reply
JohnTrack
JohnTrack Jan. 5 at 5:46 PM
$PRE waiting on clean signal...
0 · Reply
JohnTrack
JohnTrack Jan. 5 at 1:47 PM
$PRE new drop for the ticker!! https://www.rapidticker.com/news/pre-sec-filing-54fdcf
0 · Reply
topstockalerts
topstockalerts Jan. 2 at 9:40 PM
After Hours Top Gainers $GHRS $CUE $PRE $PASW $CAMP
0 · Reply
JohnTrack
JohnTrack Dec. 30 at 1:16 PM
$PRE wire mention on the company https://www.rapidticker.com/news/pre-prenetics-announces-update-to-capital-53ba91
0 · Reply
BioTechHealthX
BioTechHealthX Dec. 27 at 11:45 PM
$PRE Prenetics Global Limited (NASDAQ: PRE) is increasingly associated with consumer wellness acceleration and longevity brand demand. Discover how PRE’s health and wellness products, sports nutrition products, and global footprint are fueling a finance narrative investors are chasing for the next breakout. https://biotechhealthx.com/biotech-news/is-prenetics-global-limited-pre-the-fastest-growing-supplement-brand-story-wall-street-cant-ignore/
0 · Reply
GranularGlow
GranularGlow Dec. 27 at 5:55 PM
$PRE Short‑term swings mask the deeper question: can discipline hold; pipeline visibility needs clearer corroboration — a credible cadence of milestones would shift sentiment. Only demonstrated reliability will sustain upside potential.
0 · Reply
CartographerC
CartographerC Dec. 25 at 11:23 AM
$PRE Market behavior suggests investors are rewarding credible delivery more than theoretical upside. Progress needs to be observable in both leading indicators and reported metrics. Sharper prioritization may be required to avoid execution dilution. Future re‑rating depends on tightening the gap between narrative and reality.
0 · Reply
DARKP00L
DARKP00L Dec. 23 at 2:34 PM
$PRE 09:11 on Dec. 23 2025 Prenetics Launches Voluntary Warrant Exchange Program, Representing ~83.4% Of Outstanding Class A and B Warrants; Aims To Simplify Capital Structure, Reduce Potential Dilution By Up To 50%, Consolidate Legacy Warrants Into Single Class C Warrants #tradeideas
0 · Reply
DARKP00L
DARKP00L Dec. 23 at 2:25 PM
$PRE 09:11 on Dec. 23 2025 Prenetics Launches Voluntary Warrant Exchange Program, Representing ~83.4% Of Outstanding Class A and B Warrants; Aims To Simplify Capital Structure, Reduce Potential Dilution By Up To 50%, Consolidate Legacy Warrants Into Single Class C Warrants #tradeideas
0 · Reply
SuperGreenToday
SuperGreenToday Dec. 18 at 12:13 AM
$PRE Share Price: $15.93 Contract Selected: Nov 20, 2026 $10 Calls Buy Zone: $2.55 – $3.15 Target Zone: $4.85 – $5.93 Potential Upside: 80% ROI Time to Expiration: 337 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
Sidoti
Sidoti Dec. 10 at 6:39 PM
The Prenetics Global Limited ($PRE) Management Team presented today at the Sidoti Year End Virtual Conference. Watch the replay here: https://sidoti.zoom.us/webinar/register/WN_xAJmgJ0VSxK5S1eK2bMNHQ
1 · Reply
Merlintrader
Merlintrader Nov. 20 at 8:28 PM
$PRE https://www.merlintrader.com/top-10-healthcare-small-caps-stocks/
0 · Reply
DARKP00L
DARKP00L Nov. 4 at 1:33 PM
$PRE 08:06 on Nov. 04 2025 Prenetics Global Limited Announces Its IM8 Health And Longevity Brand Achieved A Record $108M In Annualized Recurring Revenue In October #tradeideas
0 · Reply
MahiMe
MahiMe Nov. 4 at 1:10 PM
$PRE $PRE Prenetics’ IM8 Achieves Record $9 Million in Revenue for October, Surpasses $108 Million in Annualized Recurring Revenue 11 Months After Launch https://www.stocktitan.net/news/PRE/prenetics-im8-achieves-record-9-million-in-revenue-for-october-gbhmu4cglnz6.html
0 · Reply
AStrokeOfLuck
AStrokeOfLuck Oct. 31 at 2:04 PM
$PRE
0 · Reply
Nova_Trades
Nova_Trades Oct. 31 at 1:21 PM
$PRE Prenetics adds 100 Bitcoin to its treasury, strengthening its crypto position. Meanwhile, IM8 hits a major milestone — $100M in annual recurring revenue.
0 · Reply
Stock_Catcher
Stock_Catcher Oct. 31 at 12:32 PM
$PRE Prenetics Bolsters Bitcoin Treasury with Strategic Acquisition of 100 Bitcoin, IM8 Reaches $100M ARR
0 · Reply
DrLohengrin123
DrLohengrin123 Oct. 29 at 7:21 PM
$PRE Looking good
0 · Reply
anachartanalyst
anachartanalyst Oct. 29 at 4:02 PM
$PRE https://anachart.com/wp-content/uploads/ana_temp/1761753753_soc-img.jpg
0 · Reply
DARKP00L
DARKP00L Oct. 29 at 3:03 PM
$PRE 10:24 on Oct. 29 2025 Cantor Fitzgerald Maintains Overweight on Prenetics Global, Raises Price Target to $32 #tradeideas
0 · Reply
DARKP00L
DARKP00L Oct. 29 at 2:45 PM
$PRE 10:24 on Oct. 29 2025 Cantor Fitzgerald Maintains Overweight on Prenetics Global, Raises Price Target to $32 #tradeideas
0 · Reply